Category
Cancer
Sub Category
Colon
Study Name
E7208:A Randomized Phase II study of Irinotecan and Cetuximub with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild type Colorectal Cancer following Progression on Bevacizumab-Containing Chemotherapy
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance